ARTICLE | Clinical News
Rayaldee: Phase III data
November 3, 2014 8:00 AM UTC
Top-line data from the second of 2 identical, double-blind, U.S. Phase III trials in 216 patients with stage III or IV CKD and vitamin D insufficiency showed that once-daily Rayaldee for 6 months met ...